The effectiveness and value of belimumab and voclosporin for lupus nephritis

Oct 1, 2021Journal of managed care & specialty pharmacy

How well belimumab and voclosporin work for treating lupus kidney inflammation

AI simplified

Abstract

Funding for this summary was contributed by multiple health organizations to the Institute for Clinical and Economic Review (ICER).

  • ICER evaluates evidence on the value of health care interventions.
  • Annual policy summit is supported by dues from various health care companies.
  • Funding sources include AbbVie, Aetna, and Pfizer, among others.
  • Certain individuals received funding from ICER for related work.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free